Adaptive Biotechnologies Corporation · NASDAQ:ADPT

Owen Katey Einterz sold 9,615 Adaptive Biotechnologies Corporation shares (Form 4)

Traded Aug 26, 2026 · Filed Aug 28, 2026

On Aug 26, 2026, Owen Katey Einterz (Director) sold 9,615 Adaptive Biotechnologies Corporation shares at US$26.00 for US$250K, leaving 78,639 shares. Filed Aug 28, 2026 (Form 4).

Sold
9,615 shares
Price
US$26.00
Value
US$250K
Holding after
78,639 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 26, 2026Common StockSale9,615US$26.0078,639Direct

Source

View original at SEC

Related